Logo image of BGY

BLACKROCK ENH INTL DVD TR (BGY) Stock Overview

USA - NYSE:BGY - US0925241079

5.71 USD
0 (0%)
Last: 10/17/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BGY. BGY was compared to 0 industry peers in the Unkown industry. BGY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BGY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BGY was profitable.
In the past year BGY had a positive cash flow from operations.
BGY Yearly Net Income VS EBIT VS OCF VS FCFBGY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA 7.29%
ROE 7.38%
ROIC 1.09%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BGY Yearly ROA, ROE, ROICBGY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2 4 6 8 10

1.3 Margins

Industry RankSector Rank
OM 53.06%
PM (TTM) 282.07%
GM 56.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BGY Yearly Profit, Operating, Gross MarginsBGY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 100 200 300 400 500

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BGY has been reduced compared to 1 year ago.
There is no outstanding debt for BGY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BGY Yearly Shares OutstandingBGY Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M
BGY Yearly Total Debt VS Total AssetsBGY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 44.57 indicates that BGY is not in any danger for bankruptcy at the moment.
BGY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 44.57
ROIC/WACCN/A
WACCN/A
BGY Yearly LT Debt VS Equity VS FCFBGY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 200M 400M 600M

2.3 Liquidity

BGY has a Current Ratio of 1.10. This is a normal value and indicates that BGY is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.10 indicates that BGY should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
BGY Yearly Current Assets VS Current LiabilitesBGY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.55% over the past year.
BGY shows a decrease in Revenue. In the last year, the revenue decreased by -4.61%.
EPS 1Y (TTM)4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)-4.61%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BGY Yearly Revenue VS EstimatesBGY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 5M 10M 15M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.41, which indicates a correct valuation of BGY.
When comparing the Price/Earnings ratio of BGY to the average of the S&P500 Index (27.40), we can say BGY is valued rather cheaply.
Industry RankSector Rank
PE 12.41
Fwd PE N/A
BGY Price Earnings VS Forward Price EarningsBGY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.84
EV/EBITDA N/A
BGY Per share dataBGY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

BGY has a Yearly Dividend Yield of 8.21%, which is a nice return.
BGY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 8.21%

5.2 History

BGY has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
BGY Yearly Dividends per shareBGY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

BGY pays out 107.14% of its income as dividend. This is not a sustainable payout ratio.
DP107.14%
EPS Next 2YN/A
EPS Next 3YN/A
BGY Yearly Income VS Free CF VS DividendBGY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 20M 40M 60M 80M
BGY Dividend Payout.BGY Dividend Payout, showing the Payout Ratio.BGY Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK ENH INTL DVD TR

NYSE:BGY (10/17/2025, 8:04:00 PM)

5.71

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)09-03 2025-09-03
Earnings (Next)03-05 2026-03-05
Inst Owners47.27%
Inst Owner Change0.17%
Ins OwnersN/A
Ins Owner Change0%
Market Cap517.38M
Analysts0
Price TargetN/A
Short Float %0.26%
Short Ratio1.16
Dividend
Industry RankSector Rank
Dividend Yield 8.21%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP107.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date10-15 2025-10-15 (0.0426)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.41
Fwd PE N/A
P/S 34.75
P/FCF 4.84
P/OCF 4.84
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)0.46
EY8.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.18
FCFY20.68%
OCF(TTM)1.18
OCFY20.68%
SpS0.16
BVpS6.28
TBVpS6.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.29%
ROE 7.38%
ROCE 1.38%
ROIC 1.09%
ROICexc 1.09%
ROICexgc 1.09%
OM 53.06%
PM (TTM) 282.07%
GM 56.01%
FCFM 718.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 254.76%
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 44.57
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.61%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.92%
OCF growth 3YN/A
OCF growth 5YN/A